Merck and Ridgeback Therapeutics Inc.’s promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take a pill at home that can keep them from getting severely sick.
Merck and Ridgeback Therapeutics Inc.’s promising oral antiviral could shift the direction of the pandemic by making it easier for people with COVID-19 to take a pill at home that can keep them from getting severely sick.